Fairvalue-Calculator Fairvalue-Calculator
EN DE

Microbix Biosystems Inc (MBXBF) Fair Value & Analysis

Healthcare · US · Market cap $30.1M

Price$0.2100
Fair Value$0.6400
Upside+204.8%
Quality95/100
Evidence: Low Range $0.4800 – $0.8000

Fair value as of: Jun 24, 2026

Analysis

Microbix Biosystems Inc (MBXBF) currently trades at $0.2100, while our model-based Fair Value estimate is $0.6400 — implying the stock looks roughly 204.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Microbix Biosystems Inc (MBXBF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.6400 versus a price of $0.2100 — about +205% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MBXBF?
Our 21-model fair value for Microbix Biosystems Inc is $0.6400 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.2100.
What is the quality score of MBXBF?
Microbix Biosystems Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.